Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
McManus et al show the difficulties inherent in using currently
available risk scoring systems for cardiovascular disease, with only
moderate agreement between methods.1 They also show the
methods' relatively low accuracy when compared with independently calculated Framingham risk estimates.
Much of the inaccuracy was due to a lack of risk factor information in case records and use of risk scoring in people with diagnosed cardiovascular disease, who should be considered at high risk and treated accordingly. As in previous comparison studies, the Framingham risk equations were used as the gold standard by which the performance of all the Framingham derived risk assessment tools was evaluated.2
Important treatment decisions are being based on the findings of risk
assessment tools. Surprisingly, little effort has been put into
assessing the accuracy of the Framingham risk score in contemporary
European populations. Haq et al simply examined agreement between the
Framingham risk score
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care